All the news articles and press releases in one place.

Date / Time Source Company Sector Market Cap Announcement
08Aug22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Notice of Half-Year Financial Results
07Jul22 09:45 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Results of EGM
30Jun22 17:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Holding(s) in Company
28Jun22 13:47 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Registration of New Shares
28Jun22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Announcement of Placing
16Jun22 12:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron notice of EGM
15Jun22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Announces Top-Line 12-Month Survival Results
08Jun22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - First Patient Dosed in Ph I/II BEXMAB Combo Study
01Jun22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Exercise of options
30May22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Presentation of Biomarker Analysis at ASCO
16May22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - FDA and FIMEA approve BEXMAB study to begin
12May22 15:50 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Ex Vivo Data Presented at EHA2022 Congress
09May22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Mol Cancer Ther Publishes Bexmarilimab Research
04May22 11:15 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Grant of options
22Apr22 13:01 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Board Changes
22Apr22 13:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Results of AGM
21Apr22 16:30 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Presents Melanoma Data at EADO
08Apr22 15:45 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Managers’ Transactions
05Apr22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Closes HIBISCUS Trial
25Mar22 09:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Notice of Faron Pharmaceuticals Ltd’s AGM
25Mar22 07:15 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron´s Annual Report 2021 Published
25Mar22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Financial Statement January 1 to December 31 2021
14Mar22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Publishes Research From INTEREST Trial
09Mar22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Presentation of Biomarker Data at AACR 2022
07Mar22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Notice of 2021 Full-Year Results and Annual Report
04Mar22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron presents at upcoming conferences
28Feb22 17:45 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Board Issues Warrants to IPF Partners
28Feb22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Obtains Debt Funding from IPF Partners
23Feb22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Updates on Bexmarilimab Development Program
14Feb22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Announces R&D Day
03Feb22 10:40 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Scientific Reports Publishes INFORAAA Results
31Jan22 13:30 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Holdings in Company
31Jan22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Juho Jalkanen Appointed Chief Operating Officer
28Jan22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Grant of options
24Jan22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron at Proactive One2One Investor Forum
17Jan22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron to Present at Redeye Fight Cancer Seminar
05Jan22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron to Present at H.C. Wainwright BioConnect
04Jan22 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Appoints Marie-Louise Fjällskog as CMO
21Dec21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron’s financial calendar for 2022
09Dec21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Announces Topline MATINS Biomarker Analysis
01Dec21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Change in Faron’s Management Team
16Nov21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron to Present at Jefferies Conference 2021
09Nov21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron awarded EUR 3.8 Million in Arbitration Case
03Nov21 15:55 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Cellular and Molecular Life Sciences Publication
07Oct21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Exercise of options
05Oct21 11:30 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Holding(s) in Company
01Oct21 14:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Registration of Placing Shares with Trade Register
01Oct21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Results of Placing and Issue Price
30Sep21 16:31 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Proposed Issue and Placing of Shares
17Sep21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Presentation of Updated MATINS Data at ESMO
09Sep21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron Announces Presentation at ESMO Congress
07Sep21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron to Present at H.C. Wainwright Conference
26Aug21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Half-Year Financials, January 1 – June 30 2021
25Aug21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - First Patient Dosed in Phase II/III COVID-19 Trial
28Jul21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Notice of Half-Year Report
12Jul21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Faron to Host KOL Webinar on Clever-1 Receptor
22Jun21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Updated corporate presentation
14Jun21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Bexmarilimab granted key US patent
03Jun21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Bexmarilimab results published in CCR
17May21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - Bexmarilimab shows promising anti-tumour activity
14May21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron Pharma. Oy - US rights to patent related to Traumakine
10May21 14:30 RNS Faron Pharmaceuticals Oy Health £110.5m Holding(s) in Company
29Apr21 12:45 RNS Faron Pharmaceuticals Oy Health £110.5m Grant of options
23Apr21 13:45 RNS Faron Pharmaceuticals Oy Health £110.5m Result of AGM
23Apr21 13:45 RNS Faron Pharmaceuticals Oy Health £110.5m Board Change
29Mar21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Appointment of a Broker
25Mar21 07:45 RNS Faron Pharmaceuticals Oy Health £110.5m Exercise of Options
25Mar21 07:30 RNS Faron Pharmaceuticals Oy Health £110.5m Notice of Faron Pharmaceuticals Ltd’s AGM
25Mar21 07:15 RNS Faron Pharmaceuticals Oy Health £110.5m Faron´s Annual Report 2020 published
25Mar21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Financial statement January 1 to December 31 2020
22Mar21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Bexmarilimab (Clevegen) development update
11Mar21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron to Present at Oppenheimer Conference
02Mar21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron to Present at H.C. Wainwright Conference
25Feb21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Notice of Full-Year Results and Annual Report
17Feb21 16:30 RNS Faron Pharmaceuticals Oy Health £110.5m Holding(s) in Company
12Feb21 15:00 RNS Faron Pharmaceuticals Oy Health £110.5m Registration of Placing Shares
12Feb21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Results of Placing and Issue Price
11Feb21 16:30 RNS Faron Pharmaceuticals Oy Health £110.5m Proposed Issue and Placing of Shares
26Jan21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Update on TRAUMAKINE development
20Jan21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Bexmarilimab (Clevegen) development update
18Jan21 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m US Department of Defense to support TRAUMAKINE
04Jan21 07:00 RNS-R Faron Pharmaceuticals Oy Health £110.5m Faron to Present at H.C. Wainwright
21Dec20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron’s financial calendar for 2021
10Dec20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Presents at ESMO Immuno-Oncology Virtual Congress
23Nov20 07:30 RNS-R Faron Pharmaceuticals Oy Health £110.5m To Participate in Upcoming Investor Conferences
23Nov20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Bexmarilimab (Clevegen) development update
20Nov20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Issue of Equity
16Oct20 11:35 RNS Faron Pharmaceuticals Oy Health £110.5m First Results from WHO Solidarity Trial
14Oct20 14:15 RNS Faron Pharmaceuticals Oy Health £110.5m Grant of options
30Sep20 09:45 RNS Faron Pharmaceuticals Oy Health £110.5m Holding(s) in Company
24Sep20 07:15 RNS Faron Pharmaceuticals Oy Health £110.5m Exercise of options
24Sep20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Half-year Report
18Sep20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m MATINS trial data presented at ESMO
09Sep20 12:00 RNS-R Faron Pharmaceuticals Oy Health £110.5m Faron to Present at H.C. Wainwright Conference
27Aug20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Notice of Half-Year Report
18Aug20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Traumakine Update
27Jul20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Change of Adviser
08Jul20 15:00 RNS Faron Pharmaceuticals Oy Health £110.5m Managers’ transactions
16Jun20 07:01 RNS Faron Pharmaceuticals Oy Health £110.5m Faron hosts virtual R&D Day today
16Jun20 07:00 RNS Faron Pharmaceuticals Oy Health £110.5m Faron update on pipeline progress ahead of R&D Day
Date / Time Source Company % Chg
08Aug22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of Half-Year Financial Results
07Jul22 09:45 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Results of EGM
30Jun22 17:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Holding(s) in Company
28Jun22 13:47 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Registration of New Shares
28Jun22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Announcement of Placing
16Jun22 12:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron notice of EGM
15Jun22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces Top-Line 12-Month Survival Results
08Jun22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - First Patient Dosed in Ph I/II BEXMAB Combo Study
01Jun22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Exercise of options
30May22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Presentation of Biomarker Analysis at ASCO
16May22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - FDA and FIMEA approve BEXMAB study to begin
12May22 15:50 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Ex Vivo Data Presented at EHA2022 Congress
09May22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Mol Cancer Ther Publishes Bexmarilimab Research
04May22 11:15 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Grant of options
22Apr22 13:01 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Board Changes
22Apr22 13:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Results of AGM
21Apr22 16:30 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Presents Melanoma Data at EADO
08Apr22 15:45 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Managers’ Transactions
05Apr22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Closes HIBISCUS Trial
25Mar22 09:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of Faron Pharmaceuticals Ltd’s AGM
25Mar22 07:15 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron´s Annual Report 2021 Published
25Mar22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Financial Statement January 1 to December 31 2021
14Mar22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Publishes Research From INTEREST Trial
09Mar22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Presentation of Biomarker Data at AACR 2022
07Mar22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of 2021 Full-Year Results and Annual Report
04Mar22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron presents at upcoming conferences
28Feb22 17:45 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Board Issues Warrants to IPF Partners
28Feb22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Obtains Debt Funding from IPF Partners
23Feb22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Updates on Bexmarilimab Development Program
14Feb22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces R&D Day
03Feb22 10:40 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Scientific Reports Publishes INFORAAA Results
31Jan22 13:30 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Holdings in Company
31Jan22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Juho Jalkanen Appointed Chief Operating Officer
28Jan22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Grant of options
24Jan22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron at Proactive One2One Investor Forum
17Jan22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at Redeye Fight Cancer Seminar
05Jan22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at H.C. Wainwright BioConnect
04Jan22 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Appoints Marie-Louise Fjällskog as CMO
21Dec21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron’s financial calendar for 2022
09Dec21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces Topline MATINS Biomarker Analysis
01Dec21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Change in Faron’s Management Team
16Nov21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at Jefferies Conference 2021
09Nov21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron awarded EUR 3.8 Million in Arbitration Case
03Nov21 15:55 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Cellular and Molecular Life Sciences Publication
07Oct21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Exercise of options
05Oct21 11:30 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Holding(s) in Company
01Oct21 14:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Registration of Placing Shares with Trade Register
01Oct21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Results of Placing and Issue Price
30Sep21 16:31 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Proposed Issue and Placing of Shares
17Sep21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Presentation of Updated MATINS Data at ESMO
09Sep21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces Presentation at ESMO Congress
07Sep21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at H.C. Wainwright Conference
26Aug21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Half-Year Financials, January 1 – June 30 2021
25Aug21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - First Patient Dosed in Phase II/III COVID-19 Trial
28Jul21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of Half-Year Report
12Jul21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Host KOL Webinar on Clever-1 Receptor
22Jun21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Updated corporate presentation
14Jun21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Bexmarilimab granted key US patent
03Jun21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Bexmarilimab results published in CCR
17May21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Bexmarilimab shows promising anti-tumour activity
14May21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - US rights to patent related to Traumakine
10May21 14:30 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
29Apr21 12:45 RNS Faron Pharmaceuticals Oy 0.00%
Grant of options
23Apr21 13:45 RNS Faron Pharmaceuticals Oy 0.00%
Result of AGM
23Apr21 13:45 RNS Faron Pharmaceuticals Oy 0.00%
Board Change
29Mar21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Appointment of a Broker
25Mar21 07:45 RNS Faron Pharmaceuticals Oy 0.00%
Exercise of Options
25Mar21 07:30 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Faron Pharmaceuticals Ltd’s AGM
25Mar21 07:15 RNS Faron Pharmaceuticals Oy 0.00%
Faron´s Annual Report 2020 published
25Mar21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Financial statement January 1 to December 31 2020
22Mar21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Bexmarilimab (Clevegen) development update
11Mar21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron to Present at Oppenheimer Conference
02Mar21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron to Present at H.C. Wainwright Conference
25Feb21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Full-Year Results and Annual Report
17Feb21 16:30 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
12Feb21 15:00 RNS Faron Pharmaceuticals Oy 0.00%
Registration of Placing Shares
12Feb21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Results of Placing and Issue Price
11Feb21 16:30 RNS Faron Pharmaceuticals Oy 0.00%
Proposed Issue and Placing of Shares
26Jan21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Update on TRAUMAKINE development
20Jan21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Bexmarilimab (Clevegen) development update
18Jan21 07:00 RNS Faron Pharmaceuticals Oy 0.00%
US Department of Defense to support TRAUMAKINE
04Jan21 07:00 RNS-R Faron Pharmaceuticals Oy 0.00%
Faron to Present at H.C. Wainwright
21Dec20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron’s financial calendar for 2021
10Dec20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Presents at ESMO Immuno-Oncology Virtual Congress
23Nov20 07:30 RNS-R Faron Pharmaceuticals Oy 0.00%
To Participate in Upcoming Investor Conferences
23Nov20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Bexmarilimab (Clevegen) development update
20Nov20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Issue of Equity
16Oct20 11:35 RNS Faron Pharmaceuticals Oy 0.00%
First Results from WHO Solidarity Trial
14Oct20 14:15 RNS Faron Pharmaceuticals Oy 0.00%
Grant of options
30Sep20 09:45 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
24Sep20 07:15 RNS Faron Pharmaceuticals Oy 0.00%
Exercise of options
24Sep20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Half-year Report
18Sep20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
MATINS trial data presented at ESMO
09Sep20 12:00 RNS-R Faron Pharmaceuticals Oy 0.00%
Faron to Present at H.C. Wainwright Conference
27Aug20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Half-Year Report
18Aug20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Traumakine Update
27Jul20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Change of Adviser
08Jul20 15:00 RNS Faron Pharmaceuticals Oy 0.00%
Managers’ transactions
16Jun20 07:01 RNS Faron Pharmaceuticals Oy 0.00%
Faron hosts virtual R&D Day today
16Jun20 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron update on pipeline progress ahead of R&D Day
Date / Time Company % Chg
08Aug22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of Half-Year Financial Results
07Jul22 09:45 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Results of EGM
30Jun22 17:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Holding(s) in Company
28Jun22 13:47 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Registration of New Shares
28Jun22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Announcement of Placing
16Jun22 12:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron notice of EGM
15Jun22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces Top-Line 12-Month Survival Results
08Jun22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - First Patient Dosed in Ph I/II BEXMAB Combo Study
01Jun22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Exercise of options
30May22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Presentation of Biomarker Analysis at ASCO
16May22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - FDA and FIMEA approve BEXMAB study to begin
12May22 15:50 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Ex Vivo Data Presented at EHA2022 Congress
09May22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Mol Cancer Ther Publishes Bexmarilimab Research
04May22 11:15 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Grant of options
22Apr22 13:01 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Board Changes
22Apr22 13:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Results of AGM
21Apr22 16:30 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Presents Melanoma Data at EADO
08Apr22 15:45 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Managers’ Transactions
05Apr22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Closes HIBISCUS Trial
25Mar22 09:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of Faron Pharmaceuticals Ltd’s AGM
25Mar22 07:15 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron´s Annual Report 2021 Published
25Mar22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Financial Statement January 1 to December 31 2021
14Mar22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Publishes Research From INTEREST Trial
09Mar22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Presentation of Biomarker Data at AACR 2022
07Mar22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of 2021 Full-Year Results and Annual Report
04Mar22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron presents at upcoming conferences
28Feb22 17:45 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Board Issues Warrants to IPF Partners
28Feb22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Obtains Debt Funding from IPF Partners
23Feb22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Updates on Bexmarilimab Development Program
14Feb22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces R&D Day
03Feb22 10:40 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Scientific Reports Publishes INFORAAA Results
31Jan22 13:30 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Holdings in Company
31Jan22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Juho Jalkanen Appointed Chief Operating Officer
28Jan22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Grant of options
24Jan22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron at Proactive One2One Investor Forum
17Jan22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at Redeye Fight Cancer Seminar
05Jan22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at H.C. Wainwright BioConnect
04Jan22 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Appoints Marie-Louise Fjällskog as CMO
21Dec21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron’s financial calendar for 2022
09Dec21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces Topline MATINS Biomarker Analysis
01Dec21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Change in Faron’s Management Team
16Nov21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at Jefferies Conference 2021
09Nov21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron awarded EUR 3.8 Million in Arbitration Case
03Nov21 15:55 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Cellular and Molecular Life Sciences Publication
07Oct21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Exercise of options
05Oct21 11:30 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Holding(s) in Company
01Oct21 14:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Registration of Placing Shares with Trade Register
01Oct21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Results of Placing and Issue Price
30Sep21 16:31 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Proposed Issue and Placing of Shares
17Sep21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Presentation of Updated MATINS Data at ESMO
09Sep21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron Announces Presentation at ESMO Congress
07Sep21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Present at H.C. Wainwright Conference
26Aug21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Half-Year Financials, January 1 – June 30 2021
25Aug21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - First Patient Dosed in Phase II/III COVID-19 Trial
28Jul21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Notice of Half-Year Report
12Jul21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Faron to Host KOL Webinar on Clever-1 Receptor
22Jun21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Updated corporate presentation
14Jun21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Bexmarilimab granted key US patent
03Jun21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Bexmarilimab results published in CCR
17May21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - Bexmarilimab shows promising anti-tumour activity
14May21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharma. Oy - US rights to patent related to Traumakine
10May21 14:30 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
29Apr21 12:45 Faron Pharmaceuticals Oy 0.00%
Grant of options
23Apr21 13:45 Faron Pharmaceuticals Oy 0.00%
Result of AGM
23Apr21 13:45 Faron Pharmaceuticals Oy 0.00%
Board Change
29Mar21 07:00 Faron Pharmaceuticals Oy 0.00%
Appointment of a Broker
25Mar21 07:45 Faron Pharmaceuticals Oy 0.00%
Exercise of Options
25Mar21 07:30 Faron Pharmaceuticals Oy 0.00%
Notice of Faron Pharmaceuticals Ltd’s AGM
25Mar21 07:15 Faron Pharmaceuticals Oy 0.00%
Faron´s Annual Report 2020 published
25Mar21 07:00 Faron Pharmaceuticals Oy 0.00%
Financial statement January 1 to December 31 2020
22Mar21 07:00 Faron Pharmaceuticals Oy 0.00%
Bexmarilimab (Clevegen) development update
11Mar21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron to Present at Oppenheimer Conference
02Mar21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron to Present at H.C. Wainwright Conference
25Feb21 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of Full-Year Results and Annual Report
17Feb21 16:30 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
12Feb21 15:00 Faron Pharmaceuticals Oy 0.00%
Registration of Placing Shares
12Feb21 07:00 Faron Pharmaceuticals Oy 0.00%
Results of Placing and Issue Price
11Feb21 16:30 Faron Pharmaceuticals Oy 0.00%
Proposed Issue and Placing of Shares
26Jan21 07:00 Faron Pharmaceuticals Oy 0.00%
Update on TRAUMAKINE development
20Jan21 07:00 Faron Pharmaceuticals Oy 0.00%
Bexmarilimab (Clevegen) development update
18Jan21 07:00 Faron Pharmaceuticals Oy 0.00%
US Department of Defense to support TRAUMAKINE
04Jan21 07:00 Faron Pharmaceuticals Oy 0.00%
Faron to Present at H.C. Wainwright
21Dec20 07:00 Faron Pharmaceuticals Oy 0.00%
Faron’s financial calendar for 2021
10Dec20 07:00 Faron Pharmaceuticals Oy 0.00%
Presents at ESMO Immuno-Oncology Virtual Congress
23Nov20 07:30 Faron Pharmaceuticals Oy 0.00%
To Participate in Upcoming Investor Conferences
23Nov20 07:00 Faron Pharmaceuticals Oy 0.00%
Bexmarilimab (Clevegen) development update
20Nov20 07:00 Faron Pharmaceuticals Oy 0.00%
Issue of Equity
16Oct20 11:35 Faron Pharmaceuticals Oy 0.00%
First Results from WHO Solidarity Trial
14Oct20 14:15 Faron Pharmaceuticals Oy 0.00%
Grant of options
30Sep20 09:45 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
24Sep20 07:15 Faron Pharmaceuticals Oy 0.00%
Exercise of options
24Sep20 07:00 Faron Pharmaceuticals Oy 0.00%
Half-year Report
18Sep20 07:00 Faron Pharmaceuticals Oy 0.00%
MATINS trial data presented at ESMO
09Sep20 12:00 Faron Pharmaceuticals Oy 0.00%
Faron to Present at H.C. Wainwright Conference
27Aug20 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of Half-Year Report
18Aug20 07:00 Faron Pharmaceuticals Oy 0.00%
Traumakine Update
27Jul20 07:00 Faron Pharmaceuticals Oy 0.00%
Change of Adviser
08Jul20 15:00 Faron Pharmaceuticals Oy 0.00%
Managers’ transactions
16Jun20 07:01 Faron Pharmaceuticals Oy 0.00%
Faron hosts virtual R&D Day today
16Jun20 07:00 Faron Pharmaceuticals Oy 0.00%
Faron update on pipeline progress ahead of R&D Day